Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Vascular Surgery

  Free Subscription

Articles published in Arterioscler Thromb Vasc Biol

Retrieve available abstracts of 21 articles:
HTML format

Single Articles

    July 2022
  1. TANIGUCHI R, Ohashi Y, Lee JS, Hu H, et al
    Endothelial Cell TGF-beta (Transforming Growth Factor-Beta) Signaling Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula Patency.
    Arterioscler Thromb Vasc Biol. 2022;42:868-883.
    PubMed     Abstract available

    June 2022
  2. PAVASINI R, Campo G
    Ticagrelor and Endothelial Function: An Effect That Persists Far From the Acute Phase and in Monotherapy.
    Arterioscler Thromb Vasc Biol. 2022;42:799-801.

    May 2022
  3. DACANO JL, Aikawa M, Singh SA
    Promise of a Novel Bedside-to-Bench Paradigm: Can Percutaneous Coronary Intervention Proteomics Balloon Into Clinical Practice?
    Arterioscler Thromb Vasc Biol. 2022 May 26:101161ATVBAHA122317802.

    April 2022
  4. LORENTZEN LG, Hansen GM, Iversen KK, Bundgaard H, et al
    Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons.
    Arterioscler Thromb Vasc Biol. 2022 Apr 21:101161ATVBAHA122317491.
    PubMed     Abstract available

  5. TAM CF, Chan YH, Wong YK, Li Z, et al
    Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA121317513.
    PubMed     Abstract available

    March 2022
  6. CHOXI R, Kapoor K, Mackman N, Jovin IS, et al
    Direct Oral Anticoagulants and Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2022 Mar 17:ATVBAHA121317171.
    PubMed     Abstract available

    December 2021
  7. MATSUBARA ( ) Y, Gonzalez L, Kiwan G, Liu ( ) J, et al
    PD-L1 (Programmed Death Ligand 1) Regulates T-Cell Differentiation to Control Adaptive Venous Remodeling.
    Arterioscler Thromb Vasc Biol. 2021;41:2909-2922.
    PubMed     Abstract available

    August 2021
  8. KRALER S, Libby P, Evans PC, Akhmedov A, et al
    Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs.
    Arterioscler Thromb Vasc Biol. 2021;41:2237-2251.
    PubMed     Abstract available

    July 2021
  9. ALKARITHI G, Duval C, Shi Y, Macrae FL, et al
    Thrombus Structural Composition in Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2021 Jul 15:ATVBAHA120315754.
    PubMed     Abstract available

  10. MADDER RD, Kubo T, Ino Y, Kameyama T, et al
    Target Lesion Lipid Content Detected by Near-Infrared Spectroscopy After Stenting and the Risk of Subsequent Target Lesion Failure.
    Arterioscler Thromb Vasc Biol. 2021;41:2181-2189.
    PubMed     Abstract available

    June 2021
  11. CORNELISSEN A, Guo L, Fernandez R, Kelly MC, et al
    Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level.
    Arterioscler Thromb Vasc Biol. 2021 Jun 24:ATVBAHA121316472.
    PubMed     Abstract available

  12. GEORGAKIS MK, van der Laan SW, Asare Y, Mekke JM, et al
    Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability.
    Arterioscler Thromb Vasc Biol. 2021;41:2038-2048.
    PubMed     Abstract available

    March 2021
  13. FLETCHER EK, Wang Y, Flynn LK, Turner SE, et al
    Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2021 Mar 25:ATVBAHA120315837.
    PubMed     Abstract available

  14. MATSUBARA Y, Kiwan G, Liu J, Gonzalez L, et al
    Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation.
    Arterioscler Thromb Vasc Biol. 2021;41:e160-e174.
    PubMed     Abstract available

    October 2020
  15. KULIOPULOS A, Gurbel PA, Rade JJ, Kimmelstiel CD, et al
    PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study.
    Arterioscler Thromb Vasc Biol. 2020 Oct 8:ATVBAHA120315168.
    PubMed     Abstract available

    September 2020
  16. CASONATO A, Galletta E, Cella G, Barbon G, et al
    Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
    Arterioscler Thromb Vasc Biol. 2020;40:2187-2194.
    PubMed     Abstract available

    August 2020
  17. CUI NH, Yang JM, Liu X, Wang XB, et al
    Poly(ADP-Ribose) Polymerase Activity and Coronary Artery Disease in Type 2 Diabetes Mellitus: An Observational and Bidirectional Mendelian Randomization Study.
    Arterioscler Thromb Vasc Biol. 2020 Aug 6:ATVBAHA120314712.
    PubMed     Abstract available

    July 2020
  18. HU H, Lee SR, Bai H, Guo J, et al
    TGFbeta (Transforming Growth Factor-Beta)-Activated Kinase 1 Regulates Arteriovenous Fistula Maturation.
    Arterioscler Thromb Vasc Biol. 2020;40:e203-e213.
    PubMed     Abstract available

    May 2020
  19. TROIDL K, Hammerschick T, Albarran-Juarez J, Jung G, et al
    Shear Stress-Induced miR-143-3p in Collateral Arteries Contributes to Outward Vessel Growth by Targeting Collagen V-alpha2.
    Arterioscler Thromb Vasc Biol. 2020;40:e126-e137.
    PubMed     Abstract available

    March 2020
  20. BEVAN GH, White Solaru KT
    Evidence-Based Medical Management of Peripheral Artery Disease.
    Arterioscler Thromb Vasc Biol. 2020;40:541-553.
    PubMed     Abstract available

    November 2019
  21. LEE SY, Ahn JM, Mintz GS, Hong SJ, et al
    Ten-Year Clinical Outcomes of Late-Acquired Stent Malapposition After Coronary Stent Implantation.
    Arterioscler Thromb Vasc Biol. 2019 Nov 26:ATVBAHA119313602.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.